Adoptive transfer of HDVax-induced LILRB4+SEMA4a− or LILRB4+SEMA4a+ mItgb1-specific CD4+ T cells comparably ablated T3 tumour rejection in the Rag2−/− ACT assay (Fig. 3f). This evidence concerns the gene LILRB4 and neoplasm.